BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 6794745)

  • 1. Effects of diet and gliclazide on the haemostatic system of non-insulin-dependent diabetics.
    Paton RC; Kernoff PB; Wales JK; McNicol GP
    Br Med J (Clin Res Ed); 1981 Oct; 283(6298):1018-20. PubMed ID: 6794745
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of the sulphonylurea drugs gliclazide and glibenclamide on blood glucose control and platelet function.
    Klaff LJ; Vinik AI; Jackson WP; Malan E; Kernoff L; Jacobs P
    S Afr Med J; 1979 Aug; 56(7):247-50. PubMed ID: 121645
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect on platelet adhesiveness in diabetics after long-term treatment with a new oral hypoglycaemic agent, gliclazide.
    Rubinjoni Z; Turk Z; Coce F; Mustovic D; Maitre D; Skrabalo Z
    Curr Med Res Opin; 1978; 5(8):625-31. PubMed ID: 361347
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gliclazide. A preliminary review of its pharmacodynamic properties and therapeutic efficacy in diabetes mellitus.
    Holmes B; Heel RC; Brogden RN; Speight TM; Avery GS
    Drugs; 1984 Apr; 27(4):301-27. PubMed ID: 6373223
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effects of ingestion time of gliclazide in relationship to meals on plasma glucose, insulin and C-peptide levels.
    Batch J; Ma A; Bird D; Noble R; Charles B; Ravenscroft P; Cameron D
    Eur J Clin Pharmacol; 1990; 38(5):465-7. PubMed ID: 2199202
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Long-term effect of gliclazide on platelet function in diabetes].
    Pan CY
    Zhonghua Yi Xue Za Zhi; 1984 Apr; 64(4):233-5. PubMed ID: 6432285
    [No Abstract]   [Full Text] [Related]  

  • 7. The effects of gliclazide on platelet function in patients with diabetes mellitus.
    Violi F; De Mattia GC; Alessandri C; Perrone A; Vezza E
    Curr Med Res Opin; 1982; 8(3):200-3. PubMed ID: 7128193
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long term improvement in insulin response with gliclazide treatment.
    Bodansky HJ; Medback S; Cudworth AG; Rees LH; de Silva RS
    Diabete Metab; 1982 Dec; 8(4):319-22. PubMed ID: 6761187
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Medium term effect (3 months) of hypoglycemic sulfamide treatment (gliclazide) on insulin secretion of the non-insulin dependent diabetic].
    Brogard JM; Pinget M; Leconte A; Dorner M
    Rev Med Interne; 1982 Dec; 3(4):379-87. PubMed ID: 6761818
    [No Abstract]   [Full Text] [Related]  

  • 10. Effect of middle-term gliclazide treatment on insulin secretion in non-insulin dependent diabetics.
    Brogard JM; Pinget M; Dorner M
    Curr Med Res Opin; 1984; 9(1):56-63. PubMed ID: 6373160
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Home blood glucose monitoring in non-insulin-dependent diabetics: the effect of gliclazide on blood glucose and weight control, a multicentre trial.
    Shaw KM; Wheeley MS; Campbell DB; Ward JD
    Diabet Med; 1985 Nov; 2(6):484-90. PubMed ID: 2951123
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Hypoglycemic and microvascular properties of gliclazide: a review of the latest international studies].
    Lesobre B
    Sem Hop; 1983 Jun; 59(24):1827-33. PubMed ID: 6308816
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The effect of diamicron on various blood coagulation indices in patients with type II diabetes mellitus].
    Balabolkin MI; Morozova TP; Zhizhina SA; Novikova NV; Nepsha VD
    Klin Med (Mosk); 1983 Apr; 61(4):66-8. PubMed ID: 6865293
    [No Abstract]   [Full Text] [Related]  

  • 14. [Hemorheologic, metabolic and blood coagulation changes in diabetics in treatment with sulfanyl ureas].
    Cortinovis A; Crippa A; Sciacca V; Caravaggio V; Crippa M
    Minerva Med; 1988 May; 79(5):391-8. PubMed ID: 3131696
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic cause of hyperglycaemia and response to treatment in diabetes.
    Pearson ER; Starkey BJ; Powell RJ; Gribble FM; Clark PM; Hattersley AT
    Lancet; 2003 Oct; 362(9392):1275-81. PubMed ID: 14575972
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effects of gliclazide and glibenclamide on platelet function, fibrinolysis and metabolic control in diabetic patients with retinopathy (author's transl)].
    Chan TK; Chan V; Teng CS; Yeung RT
    Sem Hop; 1982 May; 58(19):1197-200. PubMed ID: 6285503
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is sulphonylurea therapy effective long term? A 3-year study with gliclazide.
    Zurro Hernandez J; Lavielle R
    Curr Med Res Opin; 1986; 10(5):351-8. PubMed ID: 3816294
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lack of effect of gliclazide on platelet aggregation in insulin-treated and non-insulin-treated diabetes: a two-year controlled study.
    Larkins RG; Jerums G; Taft JL; Godfrey H; Smith IL; Martin TJ
    Diabetes Res Clin Pract; 1988 Jan; 4(2):81-7. PubMed ID: 3125029
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-platelet effects of long-term treatment with gliclazide in diabetic patients.
    Ponari O; Civardi E; Megha S; Pini M; Portioli D; Dettori AG
    Thromb Res; 1979; 16(1-2):191-203. PubMed ID: 116387
    [No Abstract]   [Full Text] [Related]  

  • 20. A comparison of cellular actions between gliclazide and a hypoglycaemic peptide fragment of human growth hormone (hGH 6-13).
    Ng FM
    Diabetes Res Clin Pract; 1988 May; 5(1):17-24. PubMed ID: 3042343
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.